PAVmed Inc Net Income
| PAVM Stock | USD 10.80 0.22 2.08% |
As of the 9th of February, PAVmed holds the Coefficient Of Variation of 2445.19, mean deviation of 7.5, and Market Risk Adjusted Performance of 0.1382. Concerning fundamental indicators, the technical analysis model allows you to check practical technical drivers of PAVmed, as well as the relationship between them. Please check PAVmed Inc jensen alpha and downside variance to decide if PAVmed Inc is priced more or less accurately, providing market reflects its current price of 10.8 per share. Given that PAVmed has jensen alpha of 0.2148, we recommend you to check out PAVmed Inc's recent market performance to make sure the company can sustain itself at some point in the future.
PAVmed Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 1.5 K | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 25.6 M | 26.9 M | |
| Net Loss | -80.3 M | -76.3 M | |
| Net Income | 25.6 M | 26.9 M | |
| Net Income Per Share | 141.93 | 149.03 | |
| Net Income Per E B T | 1.26 | 0.78 |
PAVmed | Net Income | Build AI portfolio with PAVmed Stock |
Evaluating PAVmed's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into PAVmed Inc's fundamental strength.
Latest PAVmed's Net Income Growth Pattern
Below is the plot of the Net Income of PAVmed Inc over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in PAVmed Inc financial statement analysis. It represents the amount of money remaining after all of PAVmed Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is PAVmed's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PAVmed's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 28.43 M | 10 Years Trend |
|
Net Income |
| Timeline |
PAVmed Net Income Regression Statistics
| Arithmetic Mean | (10,480,366) | |
| Geometric Mean | 7,480,363 | |
| Coefficient Of Variation | (327.61) | |
| Mean Deviation | 24,564,572 | |
| Median | (1,776,600) | |
| Standard Deviation | 34,335,185 | |
| Sample Variance | 1178.9T | |
| Range | 128.8M | |
| R-Value | (0.03) | |
| Mean Square Error | 1256.5T | |
| R-Squared | 0.0008 | |
| Significance | 0.91 | |
| Slope | (194,775) | |
| Total Sum of Squares | 18862.5T |
PAVmed Net Income History
Other Fundumenentals of PAVmed Inc
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
PAVmed Net Income component correlations
PAVmed Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for PAVmed is extremely important. It helps to project a fair market value of PAVmed Stock properly, considering its historical fundamentals such as Net Income. Since PAVmed's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of PAVmed's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of PAVmed's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Equipment & Supplies sector continue expanding? Could PAVmed diversify its offerings? Factors like these will boost the valuation of PAVmed. Anticipated expansion of PAVmed directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every PAVmed data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (12.00) | Revenue Per Share | Quarterly Revenue Growth (0.99) | Return On Assets | Return On Equity |
Understanding PAVmed Inc requires distinguishing between market price and book value, where the latter reflects PAVmed's accounting equity. The concept of intrinsic value - what PAVmed's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push PAVmed's price substantially above or below its fundamental value.
It's important to distinguish between PAVmed's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PAVmed should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, PAVmed's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
PAVmed 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to PAVmed's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of PAVmed.
| 11/11/2025 |
| 02/09/2026 |
If you would invest 0.00 in PAVmed on November 11, 2025 and sell it all today you would earn a total of 0.00 from holding PAVmed Inc or generate 0.0% return on investment in PAVmed over 90 days. PAVmed is related to or competes with Inspira Technologies, Pheton Holdings, Tenon Medical, Biomerica, Heart Test, STRATA Skin, and Aptevo Therapeutics. PAVmed Inc. operates as a medical device company in the United States More
PAVmed Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure PAVmed's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess PAVmed Inc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 8.12 | |||
| Information Ratio | 0.0345 | |||
| Maximum Drawdown | 111.24 | |||
| Value At Risk | (10.69) | |||
| Potential Upside | 11.52 |
PAVmed Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for PAVmed's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as PAVmed's standard deviation. In reality, there are many statistical measures that can use PAVmed historical prices to predict the future PAVmed's volatility.| Risk Adjusted Performance | 0.0424 | |||
| Jensen Alpha | 0.2148 | |||
| Total Risk Alpha | (0.83) | |||
| Sortino Ratio | 0.0601 | |||
| Treynor Ratio | 0.1282 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PAVmed's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
PAVmed February 9, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0424 | |||
| Market Risk Adjusted Performance | 0.1382 | |||
| Mean Deviation | 7.5 | |||
| Semi Deviation | 7.74 | |||
| Downside Deviation | 8.12 | |||
| Coefficient Of Variation | 2445.19 | |||
| Standard Deviation | 14.12 | |||
| Variance | 199.36 | |||
| Information Ratio | 0.0345 | |||
| Jensen Alpha | 0.2148 | |||
| Total Risk Alpha | (0.83) | |||
| Sortino Ratio | 0.0601 | |||
| Treynor Ratio | 0.1282 | |||
| Maximum Drawdown | 111.24 | |||
| Value At Risk | (10.69) | |||
| Potential Upside | 11.52 | |||
| Downside Variance | 65.89 | |||
| Semi Variance | 59.96 | |||
| Expected Short fall | (9.10) | |||
| Skewness | 4.62 | |||
| Kurtosis | 30.57 |
PAVmed Inc Backtested Returns
PAVmed appears to be not too volatile, given 3 months investment horizon. PAVmed Inc maintains Sharpe Ratio (i.e., Efficiency) of 0.0566, which implies the company had a 0.0566 % return per unit of standard deviation over the last 3 months. By inspecting PAVmed's technical indicators, you can evaluate if the expected return of 0.82% is justified by implied risk. Please evaluate PAVmed's Mean Deviation of 7.5, market risk adjusted performance of 0.1382, and Coefficient Of Variation of 2445.19 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, PAVmed holds a performance score of 4. The firm holds a Beta of 4.43, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, PAVmed will likely underperform. Please check PAVmed's downside variance, as well as the relationship between the accumulation distribution and market facilitation index , to make a quick decision on whether PAVmed's historical price patterns will revert.
Auto-correlation | -0.36 |
Poor reverse predictability
PAVmed Inc has poor reverse predictability. Overlapping area represents the amount of predictability between PAVmed time series from 11th of November 2025 to 26th of December 2025 and 26th of December 2025 to 9th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of PAVmed Inc price movement. The serial correlation of -0.36 indicates that just about 36.0% of current PAVmed price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.36 | |
| Spearman Rank Test | -0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 2.19 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
PAVmed Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, PAVmed Inc reported net income of 28.43 M. This is 91.67% lower than that of the Health Care Equipment & Supplies sector and 88.06% lower than that of the Health Care industry. The net income for all United States stocks is 95.02% higher than that of the company.
PAVmed Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PAVmed's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PAVmed could also be used in its relative valuation, which is a method of valuing PAVmed by comparing valuation metrics of similar companies.PAVmed is currently under evaluation in net income category among its peers.
PAVmed ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, PAVmed's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to PAVmed's managers, analysts, and investors.Environmental | Governance | Social |
PAVmed Institutional Holders
Institutional Holdings refers to the ownership stake in PAVmed that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of PAVmed's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing PAVmed's value.| Shares | Ubs Group Ag | 2025-06-30 | 8.8 K | Cwm, Llc Duplicate | 2025-06-30 | 6.4 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 5 K | Tower Research Capital Llc | 2025-06-30 | 4.5 K | Wells Fargo & Co | 2025-06-30 | 1.4 K | Atlantic Trust Group, Llc | 2025-06-30 | 836 | Simplex Trading, Llc | 2025-06-30 | 565 | Hanson Mcclain Inc | 2025-06-30 | 295 | Jones Financial Companies Lllp | 2025-06-30 | 246 | First Manhattan Co. Llc | 2025-06-30 | 714.1 K | Geode Capital Management, Llc | 2025-06-30 | 88.7 K |
PAVmed Fundamentals
| Return On Equity | 0.17 | ||||
| Return On Asset | -0.37 | ||||
| Profit Margin | 106.72 % | ||||
| Operating Margin | (968.80) % | ||||
| Current Valuation | 43.66 M | ||||
| Shares Outstanding | 921.28 K | ||||
| Shares Owned By Insiders | 17.61 % | ||||
| Shares Owned By Institutions | 9.93 % | ||||
| Number Of Shares Shorted | 49.49 K | ||||
| Price To Earning | (6.39) X | ||||
| Price To Book | 1.20 X | ||||
| Price To Sales | 343.10 X | ||||
| Revenue | 3 M | ||||
| Gross Profit | (152 K) | ||||
| EBITDA | 29.67 M | ||||
| Net Income | 28.43 M | ||||
| Cash And Equivalents | 68.47 M | ||||
| Cash Per Share | 0.75 X | ||||
| Total Debt | 31.86 M | ||||
| Debt To Equity | 0.79 % | ||||
| Current Ratio | 1.82 X | ||||
| Book Value Per Share | 11.00 X | ||||
| Cash Flow From Operations | (33.55 M) | ||||
| Short Ratio | 1.89 X | ||||
| Earnings Per Share | (12.00) X | ||||
| Target Price | 285.0 | ||||
| Number Of Employees | 39 | ||||
| Beta | 0.97 | ||||
| Market Capitalization | 9.95 M | ||||
| Total Asset | 30.66 M | ||||
| Retained Earnings | (254.97 M) | ||||
| Working Capital | (33.28 M) | ||||
| Current Asset | 1.97 M | ||||
| Current Liabilities | 842 K | ||||
| Net Asset | 30.66 M |
About PAVmed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PAVmed Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PAVmed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PAVmed Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Will Health Care Equipment & Supplies sector continue expanding? Could PAVmed diversify its offerings? Factors like these will boost the valuation of PAVmed. Anticipated expansion of PAVmed directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every PAVmed data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (12.00) | Revenue Per Share | Quarterly Revenue Growth (0.99) | Return On Assets | Return On Equity |
Understanding PAVmed Inc requires distinguishing between market price and book value, where the latter reflects PAVmed's accounting equity. The concept of intrinsic value - what PAVmed's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push PAVmed's price substantially above or below its fundamental value.
It's important to distinguish between PAVmed's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PAVmed should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, PAVmed's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.